Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Gender differentiation in pharmaceutical intervention during the COVID-19 pandemic with benzodiazepines: expectation versus reality?

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: PPR-006
  • By: ALBERTO ARMAS, Daida (Universidad de La Laguna (ULL), Spain)
  • Co-author(s): Dr Daida Alberto Armas, Community Pharmacy/ Toxicology Department (Universidad de La Laguna (ULL), San Cristóbal de La Laguna, Spain)
    Prof.Dr. Carmen Rubio Armendáriz, Toxicology Department (Universidad de La Laguna (ULL), San Cristóbal de La Laguna, Spain)
    Prof.Dr. Arturo Hardisson de la Torre, Toxicology Department (Universidad de La Laguna (ULL), San Cristóbal de La Laguna, Spain)
  • Abstract:

    Background information:
    Pharmaceutical Intervention (PI) focuses on parameters such as drug efficacy and safety in order to optimize the drug using process. Benzodiazepines (BZD) have been identified as a target therapeutic group for Pharmaceutical Care because of the potential risks associated with their inefficacy and unsafety especially..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses